José Fernández‐Piqueras

Author

Also Known As

Fernández-Piqueras, José, J Fernandez-Piqueras, J Fernández-Piqueras, J. Fernandez-Piqueras, J. Fernandezpiqueras, J. Fernandez‐Piqueras, J. Fernández-Piqueras, J. Fern�ndez-Piqueras, J.. Fernández-Piqueras, Jose Fernandez-Piqueras

175

Publications

3.3K

Citations

H-Index

102

Concepts

All Affiliations

Universidad Autónoma de Madrid Centro de Biología Molecular Severo Ochoa Hospital Universitario Fundación Jiménez Díaz Instituto de Salud Carlos III Consejo Superior de Investigaciones Científicas

About

José Fernández‐Piqueras is an author at Universidad Autónoma de Madrid specializing in medicine, genetics, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	27	1.3K
2	Natural Sciences	7	7	559
3	Engineering	2	2	78
4	Public Health	2	2	22
5	Social Sciences	1	1	30

José Fernández‐Piqueras

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression María J. Bueno, Ignacío Pérez de Castro, Marta Gómez de Cedrón, Cancer Cell Epigenetic SilencingMicrorna-203 Enhances Abl1Bcr-abl1 Oncogene ExpressionMedicineGenetics	2008	455
Role of Cannabinoid Receptor CB2 in HER2 Pro-oncogenic Signaling in Breast Cancer Eduardo Pérez-Gómez, Clara Andradas, Sandra Blasco-Benito, JNCI Journal of the National Cancer Institute	2015	117
Multiple E2F-Induced MicroRNAs Prevent Replicative Stress in Response to Mitogenic Signaling María J. Bueno, Marta Gómez de Cedrón, Usua Laresgoiti, Molecular and Cellular Biology Transcriptional RegulationSystems BiologyMitogenic StimulationCell DivisionCell Signaling	2010	100
Pathological gambling and DNA polymorphic markers at MAO-A and MAO-B genes Ángela Ibáñez, Ignacío Pérez de Castro, José Fernández‐Piqueras, Molecular Psychiatry Pathological GamblingDna Polymorphic MarkersGenetic DisorderGeneticsHuman Polymorphism	2000	94
Hypermethylation of a 5′ CpG island of p16 is a frequent event in non-Hodgkin’s lymphoma Beatriz Martı́nez-Delgado, José Fernández‐Piqueras, Eva Arranz, Leukemia Frequent EventTumor BiologyLymphoid NeoplasiaCpg IslandSurgical Pathology	1997	83
Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma Ernesto de la Cueva, Isabel García‐Cao, M. Herranz, Oncogene MedicinePathologyTumorigenic ActivityTumor SuppressorCancer Genetics	2006	78
Inactivation of the cyclin-dependent kinase inhibitor p15INK4b by deletion and de novo methylation with independence of p16INK4a alterations in murine primary T-cell lymphomas Marcos Malumbres, Ignacío Pérez de Castro, Javier Santos, Oncogene Cancer ResearchLymphoid NeoplasiaPathologyP16ink4a AlterationsTumor Suppressor	1997	73
Specific quantification of human genomes from low copy number DNA samples in forensic and ancient DNA studies. Antonio Alonso, Pablo Martı́n, Cristina Albarrán, PubMed Genetic TestingDnaEngineeringDifferent Real-time PcrGenetics	2003	63
Dynamic mosaicism involving an unstable supernumerary der(22) chromosome in cat eye syndrome Miguel Urioste, G. Visedo, Amparo Sanchís, American Journal of Medical Genetics	1994	61
Combinatorial effects of microRNAs to suppress the Myc oncogenic pathway María J. Bueno, Marta Gómez de Cedrón, Gonzalo Goméz-López, Blood	2011	61

Page 1